This HTML5 document contains 64 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q62110464
rdf:type
wikibase:Item
schema:description
clinical trial клінічне випробування klinisch onderzoek ensayu clínicu
rdfs:label
Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
skos:prefLabel
Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
schema:name
Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
p:P1476
wds:Q62110464-2200C2DC-9D1F-4042-A6BF-A834C6C20D6C
wdt:P1476
A Phase II Evaluation of Cetuximab (C225, NSC #714692) in Combination With Carboplatin (NSC #241240) in the Treatment of Recurrent Platinum-Sensitive Ovarian or Primary Peritoneal Cancer
p:P582
wds:Q62110464-1D456742-4A98-4B8D-B7D4-3CE34B5643DF
wdt:P582
2006-04-01T00:00:00Z
p:P31
wds:Q62110464-922AFD60-158B-404C-9F08-43F2135F5BCF
wdt:P31
wd:Q30612
p:P580
wds:Q62110464-AF8AE2C4-2992-44AC-9B01-4C581C0316A1
wdt:P580
2004-06-01T00:00:00Z
p:P17
wds:Q62110464-36EFC171-E9C3-486B-BB9D-55A0774C888E wds:Q62110464-6202190D-5C90-49C2-B3B4-DE730B71CCDB wds:Q62110464-C33D9DC8-DD19-46B9-BB7F-7B44594741D5 wds:Q62110464-C3EF3AD7-A457-4F57-801E-1D8CE8D28C0A wds:Q62110464-CA7F5ABB-03B4-4A57-891E-C89DB59112B4
wdt:P17
wd:Q30 wd:Q408 wd:Q16 wd:Q17 wd:Q20
p:P6153
wds:Q62110464-A1A01416-711E-4088-9C7C-C356D63E6B28 wds:Q62110464-AFD91C4E-0D1F-44B3-AA77-369BBDB7EEFF wds:Q62110464-6F109248-4E9C-426C-A972-08CD52AEEA8A wds:Q62110464-7416A750-6BF0-4763-9578-11FDFB36AC5E wds:Q62110464-D4F6554A-5D7D-4789-A7FD-D46D121F275C wds:Q62110464-E3D3D904-5A59-4824-8249-50B315ADF5E2 wds:Q62110464-F3F6008F-4722-475C-9BD0-26D7E2F8193F wds:Q62110464-B1C0379E-B9D0-4FAA-9575-6C10B3DA6D0A wds:Q62110464-0B85B566-B98D-45F4-B75E-A5C0DE8677BE wds:Q62110464-1C3C1799-AACA-4812-8CE1-1DC876642050 wds:Q62110464-6B14C518-69C0-484F-8708-16A8585ED538 wds:Q62110464-2CE699D7-32DA-4466-A5FD-410502B2EC04
wdt:P6153
wd:Q7895818 wd:Q1452369 wd:Q1808012 wd:Q30269543 wd:Q30269547 wd:Q29052 wd:Q3417050 wd:Q640652 wd:Q49117 wd:Q7370121 wd:Q50037211 wd:Q1535116
p:P4844
wds:Q62110464-4220F371-7B89-43D8-BEC5-ECF936604234 wds:Q62110464-45C5CE5A-E3AF-4EA3-AE54-EBD7C5B9B4E0
wdt:P4844
wd:Q415588 wd:Q420296
p:P859
wds:Q62110464-4F80E706-9484-471F-B442-274ADAAAE321
wdt:P859
wd:Q5625184
p:P8363
wds:Q62110464-72AA2C12-79CF-4E02-B78A-7831E4A9A758
wdt:P8363
wd:Q78089383
p:P3098
wds:Q62110464-C2A93B48-5119-433D-A095-6FAD407FAED6
wdt:P3098
NCT00086892
p:P6099
wds:Q62110464-35143EC7-277C-46B4-9533-D969277C1783
wdt:P6099
wd:Q42824440
p:P8005
wds:Q62110464-7BC97792-F59F-465A-B4A4-DCFE4987C838
wdt:P8005
wd:Q76651189